Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Dec;13(6):529-39.
doi: 10.7785/tcrtexpress.2013.600273. Epub 2013 Dec 6.

GyneScan: an improved online paradigm for screening of ovarian cancer via tissue characterization

Affiliations

GyneScan: an improved online paradigm for screening of ovarian cancer via tissue characterization

U Rajendra Acharya et al. Technol Cancer Res Treat. 2014 Dec.

Abstract

Ovarian cancer is the fifth highest cause of cancer in women and the leading cause of death from gynecological cancers. Accurate diagnosis of ovarian cancer from acquired images is dependent on the expertise and experience of ultrasonographers or physicians, and is therefore, associated with inter observer variabilities. Computer Aided Diagnostic (CAD) techniques use a number of different data mining techniques to automatically predict the presence or absence of cancer, and therefore, are more reliable and accurate. A review of published literature in the field of CAD based ovarian cancer detection indicates that many studies use ultrasound images as the base for analysis. The key objective of this work is to propose an effective adjunct CAD technique called GyneScan for ovarian tumor detection in ultrasound images. In our proposed data mining framework, we extract several texture features based on first order statistics, Gray Level Co-occurrence Matrix and run length matrix. The significant features selected using t-test are then used to train and test several supervised learning based classifiers such as Probabilistic Neural Networks (PNN), Support Vector Machine (SVM), Decision Tree (DT), k-Nearest Neighbor (KNN), and Naive Bayes (NB). We evaluated the developed framework using 1300 benign and 1300 malignant images. Using 11 significant features in KNN/PNN classifiers, we were able to achieve 100% classification accuracy, sensitivity, specificity, and positive predictive value in detecting ovarian tumor. Even though more validation using larger databases would better establish the robustness of our technique, the preliminary results are promising. This technique could be used as a reliable adjunct method to existing imaging modalities to provide a more confident second opinion on the presence/absence of ovarian tumor.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: The authors declare the absence of any conflict of interest related to the present paper. The results are novel and original.

Figures

Figure 1:
Figure 1:
Sample ultrasound images of (A) benign ovarian tumor (upper panels) (B) malignant ovarian tumor (bottom panels).
Figure 2:
Figure 2:
Block diagram of the proposed system GyneScan™ for ovarian tumor detection.

Similar articles

Cited by

References

    1. Riihimaki M, Hemminki A, Sundquist K. & Hemminki K. Time trends in survival from cancer of unknown primary: Small steps forward. Eur J Cancer 49, 2403–2410, (2013). DOI: 10.1016/j.ejca.2013.02.022. - PubMed
    1. Ibeanu OA. & Díaz-Montes TP. Outcomes in ovarian cancer among hispanic women living in the United States: A population-based analysis. Pathology Res Intl 2013, 5 (2013). DOI: 10.1155/2013/672710. - PMC - PubMed
    1. Hall M, Gourley C, McNeish I, Ledermann J, Gore M, Jayson G, Perren T, Rustin G. & Kaye S. Targeted anti-vascular therapies for ovarian cancer: Current evidence. Br J Cancer 108, 250–258, (2013). DOI: 10.1038/bjc.2012.541. - PMC - PubMed
    1. Attard G. & Kaye SB. Identifying prognostic signatures in the blood of ovarian cancer patients. Gynecol Oncol 128, 1–2, (2013). DOI: 10.1016/j.ygyno.2012.11.011. - PubMed
    1. Morris RT. & Monk BJ. Ovarian cancer: Relevant therapy, not timing, is paramount. The Lancet 376, 1120–1122, (2010). DOI: 10.1016/S0140-6736(10)61515-2. - PubMed